Biopharmaceutical Whitepapers

Managing Cell Based Potency Assays – From Development to Lifecycle Maintenance

Dr. Weihong Wang, manager of molecular and cell biology

Rapid Growth of Full Time Equivalent Staffing Programs

Travis Emig, Director, and Nathan Wisniewski, Manager, Pharmaceutical Chemistry

Analytical Strategies for Monitoring Residual Impurities Encountered in Bioprocessing

Jon S. Kaufmann, Ph.D., Director, Biopharmaceutical Services

Residual Solvents: Alternate Validated Methods

Nathan Whitford, Senior Chemist/Group Leader, Method Development and Validation

Lancaster Labs Develops Extractables Database for LC/MS Analysis

Tom Lehman, Ph.D., Manager, Method Development and Validation

EMA issues new guideline on virus safety evaluation of biotechnological investigational medicinal products

Kate Bergmann, Ph.D., Manager, Viral Safety and Viral Clearance Services